Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Long-term efficacy of (90)Y-DOTATATE in patients with nonresectable pancreatic and small bowel neuroendocrine neoplasms.
Future Oncol. 2016 Aug;12(16):1877-85. doi: 10.2217/fon-2016-0031. Epub 2016 May 9.
Future Oncol. 2016.
PMID: 27156864
Clinical Trial.
Efficacy of radionuclide treatment DOTATATE Y-90 in patients with progressive metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NETs): a phase II study.
Cwikla JB, Sankowski A, Seklecka N, Buscombe JR, Nasierowska-Guttmejer A, Jeziorski KG, Mikolajczak R, Pawlak D, Stepien K, Walecki J.
Cwikla JB, et al. Among authors: seklecka n.
Ann Oncol. 2010 Apr;21(4):787-794. doi: 10.1093/annonc/mdp372. Epub 2009 Oct 15.
Ann Oncol. 2010.
PMID: 19833821
Free article.
Clinical Trial.
Item in Clipboard
Diagnostic imaging approach to gastro-entero-pancreatic carcinomas of neuroendocrine origin - single NET center experience in Poland.
Cwikla JB, Nasierowska-Guttmejer A, Jeziorski KG, Cichocki A, Zgliczynski W, Stepień K, Seklecka N, Durlik M, Malkowski B, Walecki J.
Cwikla JB, et al. Among authors: seklecka n.
Neuro Endocrinol Lett. 2007 Dec;28(6):789-800.
Neuro Endocrinol Lett. 2007.
PMID: 18063942
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.